Baxter, Sally L.
Keenan, William T.
Athanas, Argus J.
Proudfoot, James A.
Zangwill, Linda M.
Ayyagari, Radha
Liebmann, Jeffrey M.
Girkin, Christopher A.
Patapoutian, Ardem
Weinreb, Robert N.
Funding for this research was provided by:
Heed Ophthalmic Foundation
Research to Prevent Blindness
National Institutes of Health (T15LM011271, P30EY022589, EY11008, EY026590, EY027510, EY027510, EY022039, EY021818, EY023704, EY029058, T32 EY026590, R21 EY027945)
George E. Hewitt Foundation for Medical Research
Article History
Received: 18 September 2020
Accepted: 7 October 2020
First Online: 4 November 2020
Competing interests
: Dr. Baxter, Dr. Keenan, Dr. Athanas, Mr. Proudfoot, Dr. Ayyagari, and Dr. Patapoutian declare no competing interests. Dr. Zangwill has been funded by Heidelberg Engineering, Carl Zeiss Meditech, Optovue Inc., and Topcon. Dr. Liebmann has consulted for Allergan and has been funded by Novartis. Dr. Girklin has been funded by Heidelberg Engineering. Dr. Weinreb has been funded by Carl Zeiss Meditec, Centervue, Heidelberg Engineering, Konan, National Eye Institute, and Optovue Inc, and has consulted for Aerie Pharmaceuticals, Allergan, Bausch & Lomb, and Eyenovia.